Your browser doesn't support javascript.
loading
TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling.
Zhang, Xinchao; Li, Shuyan; He, Jing; Jin, Yunjie; Zhang, Ruonan; Dong, Wenjing; Lin, Mingen; Yang, Yajing; Tian, Tongguan; Zhou, Yuefan; Xu, Yixin; Lei, Qun-Ying; Zhang, Jing; Zhang, Qing; Xu, Yanping; Lv, Lei.
Affiliation
  • Zhang X; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Li S; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • He J; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Jin Y; Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Zhang R; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Dong W; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Lin M; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Yang Y; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Tian T; Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Zhou Y; Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Xu Y; Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Lei QY; Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; The Shanghai Key Laboratory of Medical Epigenetics, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang J; Medical Research Institute, Wuhan University, Wuhan, China.
  • Zhang Q; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Xu Y; Putuo People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
  • Lv L; MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Cancer Res ; 82(11): 2097-2109, 2022 06 06.
Article in En | MEDLINE | ID: mdl-35176127
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Dioxygenases / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Dioxygenases / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Year: 2022 Document type: Article Affiliation country: Country of publication: